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Abstract
Background: Contingency management (CM) has recently shown efficacy in promoting abstinence and retention
in treatment among crack cocaine users in Brazil. However, partially because of unawareness and resistance among
health care providers, CM has not been widely employed. The objective of this study was to conduct a secondary
analysis in order to evaluate how CM participants perceive their treatment experience.
Methods: Twenty-seven crack cocaine users, previously assigned to 12 weeks of CM treatment, were assessed with
a structured questionnaire designed to assess their personal opinion of, difficulty in understanding, and acceptance
of the CM intervention, as well as their opinion regarding its impact on their treatment responses.
Results: Descriptive analyses showed that 92.6% of the participants found it very easy to understand the CM
protocol. All participants reported liking their CM experience quite a bit. For the perceived effects of CM on their
treatment response, 81.5% of the participants stated that CM helped them considerably, the mean score for the
impact of CM on treatment response (out of a maximum of 10) being 9 (SD = 1.5). When asked if they believed CM
could help other people with crack cocaine dependence, 92.6% of the participants stated that CM could help such
people a lot and 7.4% stated that it could help them a little.
Conclusions: From the perspective of the patients, CM was easily assimilated, easily accepted, and had a direct
positive effect on treatment response. These findings provide additional support for the incorporation of CM into
substance abuse treatment services in Brazil.
Keywords: Crack cocaine, Contingency management, Behavioral treatment, Ambulatory treatment,
Treatment acceptance, Brazil
Background
In the last 20 years, the demand for crack cocaine depend-
ence treatment has increased drastically in Brazil, and crack
cocaine use has become a severe health concern in the
country [1, 2]. In Brazil, crack cocaine use is associated with
high rates of psychiatric comorbidities, cognitive impair-
ment, unemployment, homelessness, sexually transmitted
infections, involvement in illegal activities, incarceration,
and death [3–10]. When compared to snorted cocaine
users, crack cocaine users present poor treatment outcomes
[11], with high dropout rates [6] and low post-treatment
abstinence rates [12].
The use of Contingency Management (CM) to treat sub-
stance use disorders has been studied in the United States
[13–15], Spain [16–18], the United Kingdom [19] and China
[20] over the last 30 years. CM interventions are based on
operant behavior principles that acknowledge that a specific
response will have a greater likelihood of occurring if it is
immediately followed by a reinforcing consequence [21, 22].
Under this framework, the CM interventions deliver
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systematic rewards (such as vouchers with a monetary
value) contingent upon specific desirable responses (such as
objective verification of abstinence) [23, 24].
A recent randomized clinical trial conducted in the city
of São Paulo, Brazil, presented strong evidence that CM is
an effective treatment for crack cocaine dependence [25].
In that trial, CM was significantly more efficacious than
was usual care in increasing rates of treatment session at-
tendance and retention in treatment, as well as in redu-
cing crack cocaine use and promoting continuous
abstinence from crack cocaine. The authors also observed
significant secondary effects of CM, including reductions
in alcohol and marijuana use, as well as in post-treatment
anxiety and depressive symptomatology [25, 26].
Although CM shows promise as an effective intervention
to address the high morbidity and mortality associated with
crack cocaine use, health providers at substance abuse
treatment facilities are unaware of the positive effects of
CM on treatment responses. Given the evidence of strong
resistance to the use of CM among regular treatment staff,
as shown in studies conducted in the United States [27, 28],
it is important to provide health professionals with add-
itional information regarding the benefits of incorporating
CM into routine substance abuse treatment protocols [29].
One strategy to accomplish this is to provide crack cocaine
users with the perspectives of patients regarding their ex-
perience with the CM intervention. Therefore, the aim of
this study was to access how crack cocaine users exposed
to a CM intervention in Brazil evaluated their experience
with this novel treatment intervention.
Methods
Design
For this study, we conducted secondary analyses of data
collected in a randomized clinical trial developed between
August 2012 through to July 2015, which was designed to
evaluate the efficacy of CM in improving attendance and
retention in treatment, as well as in reducing crack co-
caine use and promoting continuous crack cocaine abstin-
ence, in a sample of crack cocaine-dependent individuals
seeking treatment at the Vila Maria Specialized Medical
Outpatient Clinic for Alcohol and Drug Treatment, lo-
cated in the northern region of the city of São Paulo [25].
Treatment at Vila Maria Outpatient clinic consisted of
90 min group therapy sessions a week that were focused
on coping skills, training and relapse prevention; 90 min
group occupational therapy weekly sessions; at least one
individual session per month with a psychiatrist; and one
individual psychotherapy session per week.
Participants
Individuals between 18 and 60 years of age, seeking treat-
ment for crack cocaine dependence, as defined by the
current criteria of the Diagnostic and Statistical Manual of
Mental Disorders, Fourth edition (DSM-IV), assessed with
the Structured Clinical Interview for DSM-IV Axis I Dis-
orders [30], were screened for eligibility. Polydrug users
were included if crack cocaine was the drug of choice.
The exclusion criteria were being abstinent from crack co-
caine for 4 or more weeks, being diagnosed with schizo-
phrenia (confirmed using the structured interview), and
not being able to attend treatment sessions three times
per week. A total of 65 individuals met the study criteria
and were enrolled in the study. Of those 65 participants,
33 were allocated to receive the CM intervention and 32
were allocated to receive the usual care intervention. All
participants provided written informed consent. The study
was approved by the Research Ethics Committee of the
Federal University of São Paulo and by the Ethics Com-
mittee from the Brazilian National Ministry of Health
(CAAE No: 00745912.4.0000.5505).
Procedure
For 12 weeks, participants allocated to the CM intervention
were encouraged to come to treatment sessions three times
per week (Mondays, Wednesdays, and Fridays), at which
time they would submit urine samples in order to identify
crack cocaine use. Participants could earn vouchers with
monetary value when they submitted samples testing nega-
tive for crack cocaine. Vouchers values increased when con-
secutive negative samples for crack cocaine were submitted
but reset to the original value if participants missed a
screening appointment or tested positive for crack cocaine.
Vouchers could be used to obtain any goods available in
the surrounding community, with the exception of tobacco
and alcohol. If abstinent for all 12 weeks of the CM inter-
vention, participants would receive a total of US$235.50 in
vouchers. For a full description of the methods employed in
the clinical trial, see Miguel et al. (2016). At the end of
treatment, a total of 27 participants (81.8%) underwent
post-treatment evaluation with a 6-item structured ques-
tionnaire designed to assess participant opinions regarding
the ease or difficulty of understanding the CM protocol, ac-
ceptance of the CM intervention, and the impact of CM on
treatment responses (Fig. 1).
For baseline variables, descriptive data analyses were con-
ducted considering the entire sample allocated to the CM
intervention (n = 33). For all variables of the 6-item struc-
tured questionnaire, descriptive data analyses were con-
ducted considering only the participants interviewed in the
post-treatment assessments (n = 27). All statistical analyses
were performed with the IBM Statistics software package,
version 22.0 (IBM Corporation, Armonk, NY, USA).
Results
The sample was predominantly male (90%) with a mean
age of 35.3 (SD = 8.7), low education achievement (mean
years of education = 8.9; SD = 3.4) and high rates of
Miguel et al. Substance Abuse Treatment, Prevention, and Policy  (2018) 13:7 Page 2 of 6
unemployment (84.8%). Nearly a fifth (18.2%) were cur-
rently living in the streets at the time of baseline assess-
ment. Regarding substance use disorders, 66.7% had
multiple substance dependence, with high prevalence of
concomitant alcohol dependence (63.6%). The presence of
other psychiatric symptomatology was also prevalent, with
nearly half of the sample (45.5%) presenting at least one
psychotic symptom, 90.9% presenting at least mild anxiety
symptomatology (accessed with de Beck Anxiety
Inventory), and all of the participants presenting at least
mild depressive symptomatology (accessed with de Beck
Depression Inventory-II).
Regarding the difficulty in understanding the CM pro-
cedure, 92.6% of the participants found it very easy to
understand, whereas 7.4% found it relatively easy to
understand. The CM intervention was well accepted by
the participants, all of whom responded, “I liked it a lot”
to the question “How do you feel about your CM experi-
ence?” For the perceived effects of CM on treatment re-
sponse, 81.5% of the participants reported that the CM
treatment helped them “a lot” in achieving their treat-
ment responses, whereas 8.5% reported that it helped
them “a little”. The mean score for the impact of CM on
treatment response reported by participants (out of a
maximum of 10) was 9 (SD = 1.5). When asked if they
would like to receive CM intervention as part of future
treatments, all participants responded, “Yes, I would like
it a lot”. Finally, 92.6% of the participants believe that
the CM intervention could help other crack cocaine-
dependent individuals, the remaining 7.4% believing that
it could help such individuals at least a little.
Discussion
Crack cocaine use has become a severe public health prob-
lem in Brazil, and treatment services are struggling to pro-
vide effective treatment for crack cocaine dependence. This
is a scenario which enlaces the sheer severity of crack co-
caine dependence, the extreme social vulnerability in which
crack cocaine dependent individuals are living in Brazil,
and the shortage of adequate treatment resources, which is
Fig. 1 Contingency management treatment experience questionnaire
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seen through the lack of evidence of efficacy in public out-
patient treatment services for this population [25]. Recent
evidence of the efficacy of CM in treating crack cocaine de-
pendence in the city of Sao Paulo suggests that CM is a vi-
able approach to addressing this public health concern.
However, treatment provider awareness and acceptance of
CM continues to be an important issue that needs to be ad-
dressed in order to promote the introduction of CM into
routine substance abuse treatment protocols in Brazil. In
the United States, despite the robust evidence of CM’s effi-
cacy in the treatment of substance use disorders, regular
clinical staff continues to show resistance to this method of
intervention [27, 28]. As a consequence, the diffusion of
CM to clinical practice in American soil has been modest
at best [31, 32]. In order to bridge-the-gap between science
and practice, the National Institute of Drug Abuse (NIDA)
has fostered the Clinical Trial Network initiative were CM
randomized clinical trials have been developed in several
outpatient treatment settings and in collaboration with
regular treatment staff [33, 34]. These trials have not only
demonstrated the effectiveness of CM when delivered in
natural outpatient clinical settings [35, 36] but also suggest
that exposing regular clinical staff to CM interventions is
effective in promoting awareness, reducing resistance and
prompting the dissemination of CM [37].
A further alternative to promote awareness of this
type of intervention and reduce resistance by treat-
ment providers is to present patients’ perspectives of
their experience with a CM intervention. The present
study provides additional knowledge of the impact of
CM interventions in crack cocaine users in Brazil by
evaluating how treatment-seeking crack cocaine users
perceived their experience with the intervention. To
our knowledge this was the first study to focus on
the participants’ perspective regarding CM interven-
tions. We found that the CM protocol was easily
understood and well accepted by the participants. In
addition, participants exposed to the CM condition
felt that it had a direct positive effect on their treat-
ment response and that it would be an effective ap-
proach to help other people who suffer from crack
cocaine dependence in Brazil. These findings offer
further support for the introduction of CM into rou-
tine substance abuse treatment protocols in Brazil.
They suggest that CM interventions are easily under-
stood, are well accepted, and have a direct positive
impact on treatment response for treatment-seeking
crack cocaine users in Brazil.
Limitations
This study has several limitations that would need to
be considered. First, our sample was small and all of
the participants were recruited from the same treat-
ment center. The results might have been different if
a greater number of participants, from multiple treat-
ment centers, had been included. Second, the data
presented in this manuscript were obtained from only
81.5% of the sample exposed to the CM condition.
Consequently, patients not retained until the post-
treatment assessments, possibly with worse treatment
responses, might have had a less favorable opinion of
CM. It is important to highlight, however, that the
Ethics Committee from the Brazilian National Minis-
try of Health prohibits the use of payment to collect
data from human subjects at baseline, end-of-
treatment and follow-up assessments. As a conse-
quence, missing data at the end-of-treatment and
follow-ups are usually higher than in countries were
participants are paid to respond to end-of-treatment
and follow-up assessments. As so, it is possible to as-
sume that the percentage of missing data observed in
this study was in part influenced by this factor.
Finally, it is important to consider that the majority
of our sample had low income and were living in ex-
tremely poor social conditions. As a consequence, CM
might have had a larger impact on their economic con-
dition than in their crack cocaine dependence treat-
ment per-se. The assessment did not differentiate these
two outcomes and therefore was unable to determine
whether, CM was more helpful by promoting periods of
continuous abstinence or by improving their economic
condition according to the participant’s perspectives. It
could have been evaluated by including questions such
as: “In your opinion, did the contingency management
intervention help you achieve periods of abstinence?”
and “Did contingency management intervention help
you in your economical condition?” in the Contingency
Management Treatment Experience Questionnaire; and
they are suggested for future studies.
Conclusions
Despite its limitations, our study provides important in-
formation on how crack users perceive the CM inter-
vention. In a country were public treatment services for
crack cocaine dependent individuals lack evidence of
efficacy, the propagation of evidence based interven-
tions is paramount. CM has recently shown efficacy in
promoting retention in treatment, reducing crack co-
caine use, promoting abstinence and also, reducing psy-
chiatric symptomatology for treatment seeking crack
cocaine dependent individuals in Sao Paulo, Brazil. This
study has shown that, according to this population, CM
was clearly and easily understood, well accepted and
had a positive effect on their treatment response. Our
results offer additional support for the applicability of
CM in outpatient public treatment settings and advo-
cates for the distribution of CM to other substance
abuse treatment centers in Brazil.
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